Research with societal impact

Four Engineering students developed a way to manipulate physical particles using only sound waves. Now they’ll present their work to global academics and industry leaders in China.

Engineering Physics professor David Novog shares insights on the future of small modular reactors, exploring their potential for northern communities and the challenges that remain before deployment.

Researchers are developing rapid diagnostic tools that could reduce drug-monitoring wait times from 15 days to 10 minutes, enabling faster, more personalized mental health treatment.

Researchers discovered 71.5-million-year-old dinosaur bones that preserve the same nanoscale mineral clusters as human bone, revealing ancient biological architecture and offering insights for future biomedical implant design.

Researchers developed a modified silicone that resists clotting and immune refection by chemically bonding antifouling polymers, improving medical implant safety and expanding potential vascular applications.

Leyla Soleymani and University of Waterloo's Mahla Poudineh have created the Aptalyzer, a painless wearable device that can track molecules in the body in real time.

The 2026 MetSoc Distinguished Materials Scientist Award recognizes Phillion for his contributions to alloy solidification, microscopy, steelmaking and service to the materials community.

Anchored at McMaster’s Automotive Resource Centre within McMaster Innovation Park, the Southern Ontario Innovation Hub will bring together industry, academia and government in a single, co-located environment.

Several Faculty of Engineering faculty members are among the newly appointed or renewed CRCs, while others are recipients of the New Frontiers in Research Fund.

Tohid Didar, professor and Canada Research Chair in Nano-biomaterials, enters rare territory with the appointment, already being a Fellow of the Canadian Academy of Health Sciences

Boyang Zhang, associate professor of chemical engineering, is leading the development of organ-on-a-chip technology, which aims to accelerate drug discovery by constructing in vitro human tissue models for use in preclinical testing.

Nabil Bassim is collaborating with TechInsights and Fibics Incorporated to advance research and development for next-generation semiconductors.